MedPath

Safety and Efficacy of ESWL for Geriatric Patients With Chronic Pancreatitis

Conditions
Geriatric
Chronic Pancreatitis
Extracorporeal Shock Wave Lithotripsy
Registration Number
NCT03373682
Lead Sponsor
Changhai Hospital
Brief Summary

Pancreatic extracorporeal shock wave lithotripsy (P-ESWL) is recommended as the first-line treatment for pancreatic stones. However, how well P-ESWL performs in geriatric patients remains unclear. The investigators aimed to evaluate the safety and efficacy of P-ESWL for geriatric patients with chronic pancreatitis.

Detailed Description

This prospective observational study was conducted in patients with painful chronic pancreatitis who underwent P-ESWL. Patients aged over 65 years were included in the geriatric group; patients aged under 65 years who underwent P-ESWL in the same period were assigned to the control group. For investigation of long-term follow-up, the geriatric group were matched with patients from the control group in a 1:1 ratio. The primary outcomes were P-ESWL complications and pain relief. The secondary outcomes included: stone clearance, physical and mental health, quality of life score, and body weight.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1404
Inclusion Criteria
  • Patients with painful chronic pancreatitis and radiopaque stones of ≥5mm.
Exclusion Criteria
  • Patients with a suspected or established malignant mass or pancreatic ascites, and pregnant patients.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
P-ESWL complicationsApril 30, 2016

The complications after P-ESWL. Including post-ESWL pancreatitis, bleeding, infection, steinstrasse, and perforation. The degree of these complications will also be measured.

Pain relief by the end of follow-up periodApril 30, 2018

Participants will be followed up annually either by return visit or telephone call. Condition of abdominal pain or acute pancreatitis attack during follow-up will be measured. Pain relief at the end of the follow-up period was classified as complete relief (Izbicki pain score≤10) or partial relief (Izbicki pain score \>10 after a decrease of \>50%)

Secondary Outcome Measures
NameTimeMethod
Body weightApril 30, 2018

Body weight after treatment

Physical and mental health assessed by SF-36 questionnaireApril 30, 2018

Physical and mental health after treatment were assessed according to the scores on the SF-36 questionnaire.

Stone clearance as assessed by ERCP performed post-ESWLApril 30, 2016

Stone clearance was evaluated at the ERCP performed post-ESWL, with complete clearance defined as clearance of \>90% of the main pancreatic duct stone volume, whereas partial clearance was defined as clearance of 50%-90% of the stone volume.

Quality of life score assessed by the patientApril 30, 2018

Quality of life score after treatment were assessed by the patient and ranged from 0 to 100, with higher scores indicating a better quality of life.

Trial Locations

Locations (1)

Changhai Hospital, Second Military Medical University

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath